Restraint stress increases neuroinflammation independently of amyloid β levels in amyloid precursor protein/PS1 transgenic mice

Journal of Neurochemistry

Volumn 116, Issue 1, 2011, Pages 43-52

  Perez Nievas, Beatriz G ^a,b,c   Hammerschmidt, Thea ^a   Kummer, Markus P ^a   Terwel, Dick ^a   Leza, Juan C ^b,c   Heneka, Michael T ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Alzheimer's disease; astrocytes; behavioral stress; microglia; protein nitration

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CORTICOSTERONE; GLIAL FIBRILLARY ACIDIC PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE COURSE; GENETIC TRANSCRIPTION; GLIA CELL; HETEROZYGOSITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; IMMUNOREACTIVITY; LEARNING; LIPID PEROXIDATION; MALE; MEMORY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CEREBRAL CORTEX; HIPPOCAMPUS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PRESENILIN-1; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL;

MUS; MUS MUSCULUS;

EID: 78650121791     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07083.x     Document Type: Article

References (51)

1. Arnold S. E., Hyman B. T., Flory J., Damasio A. R., and, Van Hoesen G. W., (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1, 103-116.
2. De Bruin V. M. S., Vieira M. C. M., Rocha M. N. M., and, Viana G. S. B., (2002) Cortisol and dehydroepiandosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementia. Brain Cogn. 50, 316-323.
3. Christen Y., (2000) Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71, 621S-629S.
4. Coyle J. T., and, Puttfarcken P., (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
5. Csernansky J. G., Dong H., Fagan A. M., Wang L., Xiong C., Holtzman D. M., and, Morris J. C., (2006) Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am. J. Psychiatry 163, 2164-2169.
6. Das N. P., and, Ratty A. K., (1987) Studies on the effects of the narcotic alkaloids, cocaine, morphine, and codeine on nonenzymatic lipid peroxidation in rat brain mitochondria. Biochem. Med. Metab. Biol. 37, 258-264.
7. Dellu F., Mayo W., Vallée M., Le Moal M., and, Simon H., (1994) Reactivity to novelty during youth as a predictive factor of cognitive impairment in the elderly: a longitudinal study in rats. Brain Res. 653, 51-56.
8. Deshmukh V. D., and, Deshmukh S. V., (1990) Stress-adaptation failure hypothesis of Alzheimer's disease. Med. Hypotheses 32, 293-295.
9. Dirnagl U., Iadecola C., and, Moskowitz M. A., (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
10. Dong H., Yuede C. M., Yoo H., Martin M. V., Deal C., Mace A. G., and, Csernansky J. G., (2008) Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice. Neuroscience 155, 154-163.
11. Dunn A. J., Wang J., and, Ando T., (1999) Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol. 461, 117-127.
12. Flint M. S., Depree K. M., Rich B. A., and, Tinkle S. S., (2003) Differential regulation of sensitizer-induced inflammation and immunity by acute restraint stress in allergic contact dermatitis. J. Neuroimmunol. 140, 28-40.
13. Glass C. K., Saijo K., Winner B., Marchetto M. C., and, Gage F. H., (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934.
14. Good P. F., Werner P., Hsu A., Olanow C. W., and, Perl D. P.,. (1996) Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149, 21-28.
15. Green K. N., Billings L. M., Roozendaal B., McGaugh J. L., and, LaFerla F. M., (2006) Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 26, 9047-9056.
16. Hartmann A., Veldhuis J. D., Deuschle M., Standhardt H., and, Heuser I., (1997) Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol. Aging 18, 285-289.
17. Kim J. J., and, Diamond D. M., (2002) The stressed hippocampus, synaptic plasticity and lost memories. Nat. Rev. Neurosci. 3, 453-462.
18. Jardanhazi-Kurutz D., Kummer M. P., Terwel D., Vogel K., Dyrks T., Thiele A., and, Heneka M. T., (2010) Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits. Neurochem. Int. Available at: (Accessed 7 July 2010).
19. Landfield P. W., Blalock E. M., Chen K., and, Porter N. M.,. (2007) A new glucocorticoid hypothesis of brain aging: implications for Alzheimer's disease. Curr. Alzheimer Res. 4, 205-212.
20. Lauterborn J. C.,. (2004) Stress induced changes in cortical and hypothalamic c-fos expression are altered in fragile X mutant mice. Brain Res. Mol. Brain Res. 131, 101-109.
21. Lee K., Kim J., Seo J., Kim T., Im J., Baek I., Kim K., Lee J., and, Han P.,. (2009) Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. J. Neurochem. 108, 165-175.
22. Lovell M. A., Ehmann W. D., Butler S. M., and, Markesbery W. R., (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
23. Lucas S., Rothwell N. J., and, Gibson R. M., (2006) The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (Suppl. 1), S232-S240.
24. Madrigal J. L., Moro M. A., Lizasoain I., Lorenzo P., Castrillo A., Boscá L., and, Leza J. C.,. (2001a) Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J. Neurochem. 76, 532-538.
25. Madrigal J. L., Olivenza R., Moro M. A., Lizasoain I., Lorenzo P., Rodrigo J., and, Leza J. C., (2001b) Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 24, 420-429.
26. Madrigal J. L. M., Hurtado O., Moro M. A., Lizasoain I., Lorenzo P., Castrillo A., Boscá L., and, Leza J. C., (2002) The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 26, 155-163.
27. Maes M., Song C., Lin A., et al. (1998) The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10, 313-318.
28. Marcus D. L., Thomas C., Rodriguez C., Simberkoff K., Tsai J. S., Strafaci J. A., and, Freedman M. L., (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150, 40-44.
29. McEwen B. S., (1999) Stress and the aging hippocampus. Front. Neuroendocrinol. 20, 49-70.
30. Moghaddam B., (1993) Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 60, 1650-1657.
31. Munhoz C., Madrigal J. L. M., García-Bueno B., Pradillo J. M., Moro M. A., Lizasoain I., Lorenzo P., Scavone C., and, Leza J. C., (2004) TNF-alpha accounts for short-term persistence of oxidative status in rat brain after two weeks of repeated stress. Eur. J. Neurosci. 20, 1125-1130.
32. Nukina H., Sudo N., Komaki G., Yu X., Mine K., and, Kubo C., (1998) The restraint stress-induced elevation in plasma interleukin-6 negatively regulates the plasma TNF-alpha level. Neuroimmunomodulation 5, 323-327.
33. Palmer A. M., and, Burns M. A., (1994) Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res. 645, 338-342.
34. Peskind E. R., Wilkinson C. W., Petrie E. C., Schellenberg G. D., and, Raskind M. A., (2001) Increased CSF cortisol in AD is a function of APOE genotype. Neurology 56, 1094-1098.
35. Pollerberg G. E., Schachner M., and, Davoust J., (1986) Differentiation state-dependent surface mobilities of two forms of the neural cell adhesion molecule. Nature 324, 462-465.
36. Pomara N., Greenberg W. M., Branford M. D., and, Doraiswamy P. M., (2003) Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update. Psychopharmacol. Bull. 37, 120-134.
37. Querfurth H. W., and, LaFerla F. M., (2010) Alzheimer's disease. N. Engl. J. Med. 362, 329-344.
38. Sapolsky R. M., (1990) Glucocorticoids, hippocampal damage and the glutamatergic synapse. Prog. Brain Res. 86, 13-23.
39. Sapolsky R. M., (1996) Why stress is bad for your brain. Science 273, 749-750.
40. Sapolsky R. M., (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57, 925-935.
41. Sastre M., Dewachter I., Rossner S., et al. (2006) Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. Proc. Natl Acad. Sci. USA 103, 443-448.
42. Sauro M. D., Jorgensen R. S., and, Pedlow C. T., (2003) Stress, glucocorticoids, and memory: a meta-analytic review. Stress 6, 235-245.
43. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S. D., Stern D., Sayre L. M., Monnier V. M., and, Perry G., (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl Acad. Sci. USA 91, 5710-5714.
44. Smith M. A., Rudnicka-Nawrot M., Richey P. L., Praprotnik D., Mulvihill P., Miller C. A., Sayre L. M., and, Perry G., (1995) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64, 2660-2666.
45. Smith M. A., Richey Harris. P. L., Sayre L. M., Beckman J. S., and, Perry G., (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 2653-2657.
46. Swaab D. F., Raadsheer F. C., Endert E., Hofman M. A., Kamphorst W., and, Ravid R., (1994) Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid. J. Neuroendocrinol. 6, 681-687.
47. Weiner M. F., Vobach S., Olsson K., Svetlik D., and, Risser R. C., (1997) Cortisol secretion and Alzheimer's disease progression. Biol. Psychiatry 42, 1030-1038.
48. Wilson R. S., Barnes L. L., Bennett D. A., Li Y., Bienias J. L., Mendes De. Leon. C. F., and, Evans D. A., (2005) Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology 64, 380-382.
49. Xie Q. W., Kashiwabara Y., and, Nathan C., (1994) Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708. (Pubitemid 24239438)
50. Yamasu K., Shimada Y., Sakaizumi M., Soma G., and, Mizuno D., (1992) Activation of the systemic production of tumor necrosis factor after exposure to acute stress. Eur. Cytokine Netw. 3, 391-398.
51. Yan S. D., Chen X., Schmidt A. M., Brett J., Godman G., Zou Y. S., Scott C. W., Caputo C., Frappier T., and, Smith M. A., (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl Acad. Sci. USA 91, 7787-7791.